| Ticker Symbol: | CVD |
|---|---|
| Exchange: | NYSE |
| Contact Info: | 210 Carnegie Center Princeton NJ 08540 609 452-4440 |
| CEO/President: | Joseph L. Herring |
| Industry: | Medical - Drugs / Standard Industry Code: 8731 |
| Description: | Covance Inc. is a leading contract research organization providing a widerange of product development services on a worldwide basis to thepharmaceutical, biotechnology and medical device industries. The company also provide health economics and outcomes services for managed care organizations, hospitals and other health care providers and laboratory testing services to the chemical, agrochemical and food industries. |
| Shares Outstanding: | 63,030 (000) | Market Value: | 2,477,590 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 87.11% | Number of Inst.Shareholders: | 2.00% |
| Last Quarter Sales: | 467.37 ($Mil.) | Last Quarter Net Income: | 51.11 ($Mil.) |
| Last Quarter EPS: | 0.80 | P/E Ratio: | 13 |
| Most Recent Earnings: | 0.80 on 10/22/08 | Earnings Per Share: | 3.14 |
| Most Recent Split: | Annual Dividend Rate: | 0 | |
| Most Recent Dividend: | Annual Dividend Yield: | 0% |


| PFIZER INC | -28.40 | 15.92 | |
| JOHNSON AND JOH | -13.30 | 59.27 | |
| BRISTOL MYERS S | -24.10 | 19.70 | |
| SCHERING PLOUGH | -43.90 | 15.18 | |
| MERCK CO INC | -55.10 | 25.99 |
